Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

famitinib

An orally bioavailable receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Famitinib binds to and inhibits several RTKs… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
In the last few years, the therapeutic approach for neuroendocrine neoplasms (NENs) has changed dramatically following the… Expand
Is this relevant?
2018
2018
AIM To establish and validate an ultra-high-performance liquid chromatography-tandem mass spectrometry method for the rapid and… Expand
Is this relevant?
2017
2017
AbstractBackgroundMetastatic colorectal cancer (mCRC) patients with progressive disease after all available standard therapies… Expand
Is this relevant?
2015
2015
513 Background: Colorectal cancer (CRC) is the third most frequently diagnosed cancer and is the fifth leading cause of cancer… Expand
Is this relevant?
Review
2015
Review
2015
The 2015 Gastrointestinal Cancers Symposium (San Francisco, CA, USA; January 15–17) is the world-class conference co-sponsored by… Expand
  • table 1
Is this relevant?
2015
2015
Purpose: Famitinib is a novel tyrosine kinase inhibitor. We investigated the effects of famitinib on the radiosensitivity of… Expand
Is this relevant?
2014
2014
AbstractPurpose Hypothyroidism is a common adverse event in patients treated with anti-VEGFR-2 targeting agents and may be a… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2013
2013
Famitinib is a novel multi‐targeted receptor tyrosine kinase inhibitor under development for cancer treatment. This study aims to… Expand
Is this relevant?
2013
2013
  • A. Zhou, Wen Zhang, +6 authors J. Wang
  • Cancer Chemotherapy and Pharmacology
  • 2013
  • Corpus ID: 22355164
AbstractPurpose To evaluate the safety, tolerability, pharmacokinetics and antitumor activities of famitinib (famitinib l-malate… Expand
  • table 2
  • table 1
  • table 3
  • table 4
  • table 5
Is this relevant?
2013
2013
Background Famitinib is a novel and potent multitargeting receptor tyrosine kinase inhibitor. The phase I clinical study showed… Expand
  • table 1
  • figure 1
  • table 2
Is this relevant?